Serum protein binding of prednisolone in four species
β Scribed by Mario L. Rocci Jr.; Noreen F. Johnson; William J. Jusko
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 257 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Mean minimum quantifiable level (MQL) was 0.01 K g / g . \* No sample.
The aim of this study was to determine in vitro protein binding of tolterodine and its 5-hydroxymethyl (5-HM) and N-dealkylated metabolites in serum from humans and several animal species at concentrations similar to those obtained in clinical and preclinical studies. Binding of tolterodine and the
The physiological, biochemical, and pharmacokinetic characteristics of a species are not independently existing entities but rather result from relationships among other variables. Pharmacokinetic parameters may thus be regarded as constitutional variables, i.e. they bear close functional relationsh
Keyphrases Cefazolin-rate and extent of binding to serum protein, dogs 0 Protein binding, serum-cefazolin, rate and extent, dogs Binding, serum protein-cefazolin, rate and extent, dogs 0 Antibacterials-cefazolin, rate and extent of binding to serum protein, dogs